Vertex Pharmaceuticals Quick Ratio 2006-2021 | VRTX

Historical quick ratio values for Vertex Pharmaceuticals (VRTX) over the last 10 years.
Vertex Pharmaceuticals Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2021-09-30 $8.52B $1.91B 4.45
2021-06-30 $8.14B $1.84B 4.43
2021-03-31 $8.24B $1.94B 4.24
2020-12-31 $7.85B $1.88B 4.18
2020-09-30 $7.21B $2.00B 3.60
2020-06-30 $6.48B $1.80B 3.60
2020-03-31 $5.26B $1.54B 3.42
2019-12-31 $4.66B $1.34B 3.49
2019-09-30 $4.62B $1.39B 3.32
2019-06-30 $4.57B $1.26B 3.63
2019-03-31 $4.05B $1.11B 3.66
2018-12-31 $3.72B $1.12B 3.32
2018-09-30 $3.56B $0.99B 3.59
2018-06-30 $3.29B $0.93B 3.55
2018-03-31 $2.92B $0.83B 3.53
2017-12-31 $2.54B $0.81B 3.14
2017-09-30 $2.23B $0.71B 3.14
2017-06-30 $2.09B $0.63B 3.34
2017-03-31 $1.79B $0.49B 3.65
2016-12-31 $1.75B $0.79B 2.21
2016-09-30 $1.43B $0.72B 1.98
2016-06-30 $1.39B $0.62B 2.23
2016-03-31 $1.34B $0.55B 2.43
2015-12-31 $1.35B $0.51B 2.67
2015-09-30 $1.31B $0.38B 3.49
2015-06-30 $1.25B $0.37B 3.35
2015-03-31 $1.32B $0.30B 4.38
2014-12-31 $1.52B $0.37B 4.12
2014-09-30 $1.63B $0.37B 4.39
2014-06-30 $1.34B $0.36B 3.68
2014-03-31 $1.42B $0.37B 3.80
2013-12-31 $1.57B $0.40B 3.96
2013-09-30 $1.64B $0.41B 3.99
2013-06-30 $1.70B $0.38B 4.45
2013-03-31 $1.54B $0.41B 3.79
2012-12-31 $1.56B $0.43B 3.60
2012-09-30 $1.55B $0.41B 3.81
2012-06-30 $1.51B $0.38B 3.97
2012-03-31 $1.31B $0.36B 3.66
2011-12-31 $1.22B $0.39B 3.11
2011-09-30 $1.18B $0.55B 2.15
2011-06-30 $0.78B $0.48B 1.62
2011-03-31 $0.86B $0.42B 2.06
2010-12-31 $0.00B $0.48B 0.00
2010-09-30 $0.00B $0.31B 0.00
2010-06-30 $0.00B $0.29B 0.00
2010-03-31 $0.00B $0.21B 0.00
2009-12-31 $0.00B $0.29B 0.00
2009-09-30 $0.00B $0.23B 0.00
2009-06-30 $0.00B $0.18B 0.00
2009-03-31 $0.00B $0.18B 0.00
2008-12-31 $0.00B $0.22B 0.00
2008-09-30 $0.00B $0.18B 0.00
2008-06-30 $0.00B $0.18B 0.00
2008-03-31 $0.00B $0.17B 0.00
2007-12-31 $0.00B $0.20B 0.00
2007-09-30 $0.00B $0.19B 0.00
2007-06-30 $0.00B $0.20B 0.00
2007-03-31 $0.00B $0.18B 0.00
2006-12-31 $0.00B $0.25B 0.00
2006-09-30 $0.00B $0.16B 0.00
2006-06-30 $0.00B $0.11B 0.00
2006-03-31 $0.00B $0.08B 0.00
2005-12-31 $0.00B $0.10B 0.00
2005-09-30 $0.00B $0.12B 0.00
2005-06-30 $0.00B $0.14B 0.00
2005-03-31 $0.00B $0.15B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $46.678B $6.206B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.477B 7.93
Bio-Rad Laboratories (BIO.B) United States $23.034B 46.74
QIAGEN (QGEN) Netherlands $12.874B 21.80
Biohaven Pharmaceutical Holding (BHVN) United States $7.457B 0.00
Arcus Biosciences (RCUS) United States $3.257B 0.00
Emergent Biosolutions (EBS) United States $2.378B 8.55
Myovant Sciences (MYOV) United Kingdom $1.780B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.529B 0.00
Zymeworks (ZYME) Canada $0.908B 0.00
Ambrx Biopharma (AMAM) United States $0.407B 0.00
SQZ Biotechnologies (SQZ) United States $0.345B 0.00
Enzo Biochem (ENZ) United States $0.164B 16.09